Update on posterior cortical atrophy.

Area of Science:

• Neurodegenerative dementias
• Atypical presentations of dementia
• Posterior Cortical Atrophy (PCA) syndrome

Background:

• Non-amnestic dementia presentations, such as Posterior Cortical Atrophy (PCA) syndrome, are frequently underdiagnosed.
• PCA is characterized by significant visuospatial and visuoperceptual deficits.
• While commonly associated with Alzheimer's disease pathology, PCA can also stem from Lewy body disease, corticobasal degeneration, and prion disease.

Purpose of the Study:

• To highlight the underrecognition and diagnostic delays associated with PCA.
• To emphasize the importance of understanding atypical dementia presentations for improved patient care.
• To discuss the distinct natural history and heterogeneity of PCA.

Main Methods:

• Review of current understanding of PCA, including its neuropathological underpinnings.
• Discussion of diagnostic tools such as functional and molecular imaging.
• Exploration of cerebrospinal fluid biomarkers and their utility.

Main Results:

• PCA exhibits a natural history distinct from typical Alzheimer's disease.
• Significant heterogeneity exists within PCA, with ongoing research into its causes.
• Imaging and CSF biomarkers show promise in understanding PCA, while retinal thickness measures are less effective.

Conclusions:

• Further characterization of PCA is essential.
• Enhanced awareness of atypical dementia presentations can improve the elucidation of underlying disease mechanisms.
• There are currently no effective treatments for PCA, underscoring the need for continued research.